Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.1423 | 1 | 0.5 |
Brugia malayi | Pax transcription factor protein 2 | 0.1279 | 0 | 0.5 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.1423 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.1423 | 1 | 0.5 |
Onchocerca volvulus | 0.1279 | 0 | 0.5 | |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.1279 | 0 | 0.5 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.1423 | 1 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.1423 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 100 uM | Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method | ChEMBL. | 23164660 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.